greeksoup/ stock research

Prestige Consumer Healthcare (PBH) FY2025 results: revenue $1.1 billion, up 1.1% on the year

Prestige Consumer Healthcare Inc. (PBH) reported revenue of $1.1 billion for fiscal 2025, the year ended 31 March 2025, up 1.1% on the year before. Net income was $215 million, up 2.5%, and diluted earnings per share $4.29. The figures are the company's own, from the 10-K it filed with the SEC on 9 May 2025.

Revenue
$1.1 billion
+1.1% on the year
FY2018FY2025
Operating margin
29.6%
30.4% a year earlier
FY2018FY2025
Net income
$215 million
+2.5% on the year
FY2018FY2025
Diluted EPS
$4.29
+2.9% on the year
FY2018FY2025

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2025 · Q2 FY2025 · Q3 FY2025 · Q4 FY2025

Income statement (profit and loss)

$ millionFY2025FY2024FY2023On the yearLast 8 years
Revenue1,1381,1251,128+1.1%
Cost of revenue503501502+0.5%
Gross profit634624625+1.6%
Gross margin55.8%55.5%55.4%
Operating income337342-22.4-1.7%
Operating margin29.6%30.4%-2.0%
Interest expense1.85.24.4-65.4%
Pre-tax income284276-93.9+3.0%
Income tax69.666.7-11.6+4.3%
Effective tax rate24.5%24.2%n/a
Net income215209-82.3+2.5%
Net margin18.9%18.6%-7.3%
Diluted EPS$4.29$4.17-$1.65+2.9%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2025FY2024FY2023On the yearLast 8 years
Operating cash flow252249230+1.0%
Capital expenditure8.29.67.8-13.9%
Free cash flow243239222+1.6%
Free cash flow margin21.4%21.3%19.7%
Cash from investing-17.5-20.1-11.6
Cash from financing-182-241-186
Depreciation and amortisation30.230.732.6-1.6%
Share-based compensation11.214.012.4-20.4%
Buybacks51.525.050.0+106.0%
Diluted shares, weighted50m50m50m-0.2%

Balance sheet

$ millionFY2025FY2024FY2023On the yearLast 8 years
Shareholders' equity1,8351,6551,447+10.9%
Debt9921,1261,346-11.9%
Operating lease liabilities22.77.59.9+202.0%
Finance lease liabilities20.60.21.7+11,890.7%
Other liabilities532530549+0.3%
Total liabilities and equity3,4023,3183,354+2.5%
Fixed assets74.576.570.4-2.6%
Goodwill527528528-0.1%
Intangible assets2,2952,3212,342-1.1%
Cash and equivalents97.946.558.5+110.6%
Receivables194177167+9.9%
Inventory148139162+6.5%
Other assets65.031.626.2+105.5%
Total assets3,4023,3183,354+2.5%

10-K for the year ended 31 March 2025, filed 9 May 2025: the filing.